Skip to main content
Clinical Trials/NCT04065191
NCT04065191
Unknown
Not Applicable

High-intensity Interval Training for Workplace Health Promotion: Evaluation of Feasibility and Preventive Effects in a Real-World Setting

University of Erlangen-Nürnberg Medical School1 site in 1 country300 target enrollmentMay 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Primary Prevention
Sponsor
University of Erlangen-Nürnberg Medical School
Enrollment
300
Locations
1
Primary Endpoint
Cardiorespiratory Fitness (CRF)
Last Updated
6 years ago

Overview

Brief Summary

The aim of this study is to investigate the effects of an extremely time-efficient high-intensity interval training program, performed over a period of six months in a real-world (workplace) setting, on cardiorespiratory fitness, cardiometabolic risk profile, and self-reported outcomes including perceived stress and subjective work ability in previously sedentary employees.

Registry
clinicaltrials.gov
Start Date
May 1, 2019
End Date
April 30, 2022
Last Updated
6 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
University of Erlangen-Nürnberg Medical School
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Sedentary Lifestyle over at least 1 year prior to the study

Exclusion Criteria

  • Pregnancy, Lactation
  • Psychological disorders, epilepsy, sever neurological disorders
  • Participation in other exercise- or nutrition studies within the last 6 months
  • coronary heart disease, heart failure
  • malignant disease
  • severe rheumatic or neurological disease
  • severe/unstable hypertension (resting RR: \>180/\>110 mmHg)
  • severely restricted lung function (FEV1 \<60%)
  • unstable Diabetes mellitus
  • severe orthopedic disease/restriction

Outcomes

Primary Outcomes

Cardiorespiratory Fitness (CRF)

Time Frame: 12 months [Change from Baseline to 6 months and Change from Baseline to 6 months after the end of the intervention]

CRF will be assessed by measuring maximum oxygen uptake (VO2max)

Secondary Outcomes

  • Muscle mass(12 months [Change from Baseline to 6 months and Change from baseline to 6 months after the end of the intervention])
  • Insulin sensitivity(12 months [Change from Baseline to 6 months and Change from Baseline to 6 months after the end of the intervention])
  • Inflammation status(12 months [Change from Baseline to 6 months and Change from Baseline to 6 months after the end of the intervention])
  • Total body water(12 months [Change from baseline to 6 months and change from baseline to 6 months after the end of the intervention])
  • Metabolic Syndrome Z-Score (MetS-Z-Score)(12 months [Change from Baseline to 6 months and Change from Baseline to 6 months after the end of the intervention])
  • Fat mass(12 months [Change from baseline to 6 months and change from baseline to 6 months after the end of the intervention])
  • Pain scores(12 months [Change from Baseline to 6 months and Change from Baseline to 6 months after the end of the intervention])
  • Perceived stress(12 months [Change from Baseline to 6 months and Change from Baseline to 6 months after the end of the intervention])
  • Subjective work ability(12 months [Change from Baseline to 6 months and Change from Baseline to 6 months after the end of the intervention])
  • Health-related quality of life(12 months [Change from Baseline to 6 months and Change from Baseline to 6 months after the end of the intervention])

Study Sites (1)

Loading locations...

Similar Trials